相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations
Julia A. Tree et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Discovery of Influenza Polymerase PA-PB1 Interaction Inhibitors Using an In Vitro Split-Luciferase Complementation-Based Assay
Jiantao Zhang et al.
ACS CHEMICAL BIOLOGY (2020)
The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China
David S. Hui et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Cell entry mechanisms of SARS-CoV-2
Jian Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
Katharine H. D. Crawford et al.
VIRUSES-BASEL (2020)
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial
Rob W. van der Pluijm et al.
LANCET (2020)
The Biology of Lactoferrin, an Iron-Binding Protein That Can Help Defend Against Viruses and Bacteria
Douglas B. Kell et al.
FRONTIERS IN IMMUNOLOGY (2020)
Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection
Qi Kong et al.
MOLECULAR CANCER (2020)
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
Chunlong Ma et al.
CELL RESEARCH (2020)
Pharmacological Characterization of the Mechanism of Action of R523062, a Promising Antiviral for Enterovirus D68
Chunlong Ma et al.
ACS INFECTIOUS DISEASES (2020)
Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions
So Young Kim et al.
ANTIVIRAL RESEARCH (2020)
Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition
Jia Yu et al.
BLOOD (2020)
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
Thomas Mandel Clausen et al.
CELL (2020)
Heparin-binding Peptides as Novel Therapies to Stop SARS-CoV-2 Cellular Entry and Infection
Omid Tavassoly et al.
MOLECULAR PHARMACOLOGY (2020)
Targeting Crucial Host Factors of SARS-CoV-2
Anil Mathew Tharappel et al.
ACS INFECTIOUS DISEASES (2020)
Lactoferrin for the treatment of COVID-19 (Review)
Yidan Wang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2020)
Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro
Qi Zhang et al.
CELL DISCOVERY (2020)
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
Jianhui Nie et al.
EMERGING MICROBES & INFECTIONS (2020)
Identification of NMS-873, an allosteric and specific p97 inhibitor, as a broad antiviral against both influenza A and B viruses
Jiantao Zhang et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Strategies for Oral Delivery of Metal-saturated Lactoferrin
Przemyslaw Gajda-Morszewski et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2019)
Membrane Protein of Human Coronavirus NL63 Is Responsible for Interaction with the Adhesion Receptor
Antonina Naskalska et al.
JOURNAL OF VIROLOGY (2019)
Human Antimicrobial Peptides as Therapeutics for Viral Infections
Aslaa Ahmed et al.
VIRUSES-BASEL (2019)
A Novel Capsid Binding Inhibitor Displays Potent Antiviral Activity against Enterovirus D68
Chunlong Ma et al.
ACS INFECTIOUS DISEASES (2019)
Entry of Human Coronavirus NL63 into the Cell
Aleksandra Milewska et al.
JOURNAL OF VIROLOGY (2018)
Exploring Ugi-Azide Four-Component Reaction Products for Broad-Spectrum Influenza Antivirals with a High Genetic Barrier to Drug Resistance
Jiantao Zhang et al.
SCIENTIFIC REPORTS (2018)
Combination therapy in combating cancer
Reza Bayat Mokhtari et al.
ONCOTARGET (2017)
Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses
Yanmei Hu et al.
ANTIVIRAL RESEARCH (2017)
Discovery of cyclosporine A and its analogs as broad-spectrum anti-influenza drugs with a high in vitro genetic barrier of drug resistance
Chunlong Ma et al.
ANTIVIRAL RESEARCH (2016)
Approved Antiviral Drugs over the Past 50 Years
Erik De Clercq et al.
CLINICAL MICROBIOLOGY REVIEWS (2016)
Middle East respiratory syndrome
Alimuddin Zumla et al.
LANCET (2015)
Structural characterization of human heparanase reveals insights into substrate recognition
Liang Wu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Structural characterization of human heparanase reveals insights into substrate recognition
Liang Wu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Immunomodulatory effects of lactoferrin
Tania Siqueiros-Cendon et al.
ACTA PHARMACOLOGICA SINICA (2014)
Human Coronavirus NL63 Utilizes Heparan Sulfate Proteoglycans for Attachment to Target Cells
Aleksandra Milewska et al.
JOURNAL OF VIROLOGY (2014)
A Human Coronavirus Responsible for the Common Cold Massively Kills Dendritic Cells but Not Monocytes
Mariana Mesel-Lemoine et al.
JOURNAL OF VIROLOGY (2012)
Inhibition of SARS Pseudovirus Cell Entry by Lactoferrin Binding to Heparan Sulfate Proteoglycans
Jianshe Lang et al.
PLOS ONE (2011)
Intestinal receptor targeting for peptide delivery: an expert's personal perspective on reasons for failure and new opportunities
Gregory Russell-Jones
THERAPEUTIC DELIVERY (2011)
Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading
Oleg Trott et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
Bovine lactoferrin and lactoferricin interfere with intracellular trafficking of Herpes simplex virus-1
A. K. Marr et al.
BIOCHIMIE (2009)
The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability
Frank H. Niesen et al.
NATURE PROTOCOLS (2007)
Bovine lactoferrin peptidic fragments involved in inhibition of Echovirus 6 in vitro infection
A Pietrantoni et al.
ANTIVIRAL RESEARCH (2006)
Antiviral activity of human lactoferrin: Inhibition of alphavirus interaction with heparan sulfate
BL Waarts et al.
VIROLOGY (2005)
Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface
JH Andersen et al.
JOURNAL OF MEDICAL VIROLOGY (2004)
Lactoferrin inhibits human papillomavirus binding and uptake in vitro
P Drobni et al.
ANTIVIRAL RESEARCH (2004)
Bovine lactoferrin inhibits adenovirus infection by interacting with viral structural polypeptides
A Pietrantoni et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Heparin-interacting sites of bovine lactoferrin are involved in anti-adenovirus activity
AM Di Biase et al.
JOURNAL OF MEDICAL VIROLOGY (2003)
Heparan sulfate proteoglycan as a plasma membrane carrier
M Belting
TRENDS IN BIOCHEMICAL SCIENCES (2003)
Coronavirus-related nosocomial viral respiratory infections in a neonatal and paediatric intensive care unit: a prospective study
A Gagneur et al.
JOURNAL OF HOSPITAL INFECTION (2002)
Functional fragments of ingested lactoferrin are resistant to proteolytic degradation in the gastrointestinal tract of adult rats
H Kuwata et al.
JOURNAL OF NUTRITION (2001)
Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts
JH Andersen et al.
ANTIVIRAL RESEARCH (2001)
分享论文
